Blog Archive

Friday, December 4, 2020

kzl

 

 
FILL THE SHORT TABLE
ID STOCK REMARK PRICE Field3 PRICES AMOUNT Field1 number fill prices fill dollar total filled total unit average NET LOSS Field2 REMARK
185 CIDM FILL THE SHORT KZL $0.83 500 $415.00 2000 $0.69 $1,384.00 $1,799.00 2500 $0.72 0

FILL THE SHORT TABLE
ID STOCK REMARK PRICE Field3 PRICES AMOUNT Field1 number fill prices fill dollar total filled total unit average NET LOSS Field2 REMARK
185 CIDM FILL THE SHORT KZL $0.83 500 $415.00 1000 $0.69 $692.00 $1,107.00 1500 $0.74 0

OGEN Trade table

 


2:53p ET 7/27/2021 - Benzinga
Why Did Oragenics Shares Skyrocket Tuesday?
Mentioned:OGEN

Oragenics Inc. (NYSE: OGEN) shares skyrocketed higher Tuesday after the company entered into a licensing agreement with the National Research Council of Canada to pursue the rapid development of next-generation SARS-CoV-2 vaccines.

This platform should allow productions of cell lines within six to eight weeks compared to six to nine months for traditional production.

Oragenics was up 38.33% at 86 cents at last check.

Oragenics Daily Chart Analysis

  • Shares have been falling in the last few months, but just broke out of what technical traders would call a falling wedge pattern.
  • The stock crossed above both the 50-day moving average (green), and the 200-day moving average, indicating sentiment in the stock started turning bullish.
  • These moving averages may both hold as an area of support in the future.
  • See also: Best Healthcare Penny Stocks

Key Oragenics Levels To Watch

  • The stock shot higher out of the pattern after it got the vaccine news today. The stock may see consolidation in the coming days.
  • Tuesday, it looks like the stock had trouble getting above the $1 level; this potentially could be a place of resistance in the future but it is likely still too early to call. The $1 level is a psychological resistance level for many traders who trade sub-$1 stocks.
  • The Relative Strength Index (RSI) shot higher Tuesday and now sits at 76 on the indicator. This puts it in the overbought range, showing there has been a large influx of buyers since the news was released.

What's Next For Oragenics?

Bullish traders would like to see the stock continue to rise until it runs out of gas, and then consolidate while holding some of the gains it made from the run. Consolidation is key to see if the stock is ready to make another leg up.

Bearish traders would like to see the stock fall and be unable to hold the gains from the breakout. This could mean that the stock is not ready for its next leg up. Bears would also like to see the stock fall back below the moving averages for a potential change in sentiment and trend.

Table1
ID STOCK PRICES AMOUNT Field1 number fill prices fill dollar total filled total unit average Field3 Field2 Field4 Field5 Field6
59 OGEN $0.67 4391 $2,941.97 4000 $0.43 $1,720.00 $4,661.97 8391 $0.56 TD            
0

ROBINHOOD GOLD

 Robinhood Gold: Is it worth it? It's worth if for the margin, but be SUPER CAREFUL with margin. If you were only working with that margin account money, so long as you're gaining at least that much (0.41%) in value per month

you're breaking even. ..

. Most importantly however, play safe with your margin account.


With Robinhood Goldyou can get instant access to $5k - $50k when you make a deposit, depending on your account balance.


Robinhood Gold was recently updated with new premium features and a simpler pricing structure.

 Instead of choosing your Gold tier when signing up, all users will now pay $5 a month for the premium features and 5% annual interest based on how much margin they use.

The big catch is that Robinhood sells the data that you are trying to purchase a stock to high frequency traders so that the HFT can buy it before you and sell it to you at a higher price.

 This Robinhood is stealing from the middle class to give to the ultr wealthy.

Many day traders buy and sell 1,000 shares at a time.

 That way you can make a few hundred dollars in profit on a small move in the share price.

 In order to trade 1,000 share blocks, you will need much more than $25,000. 

Ten times that would be a reasonable minimum.


Unless you have an equity balance of at least $25,000 in your account, your Robinhood Instant or Robinhood Gold account is limited to no more than three day trades in a sliding five trading day window. ... This limit applies to margin accounts (Robinhood Instant and Robinhood Gold), but not to cash accounts


Robinhood doesn't offer any of those features. You can't even sort your list alphabetically (though at least you can reorder your list manually). The lack of watchlist features makes the app unsuitable for serious stock research. Remember, if you don't research stocks thoroughly before purchasing, you're not investing.Jul 1, 2020


Investing with Robinhood is commission-free, now and forever. We don't charge you fees to open your account, to maintain your account, or to transfer funds to your account. However, self-regulatory organizations (SROs) such as the Financial Industry Regulatory Authority (FINRA) charge us a small fee for sell orders.

If you sell and then buy a security, or buy and then sell a security in the same dayyou've executed one day trade. ... Essentially, a cash account allows unlimited day trades for free if you have less than $25,000 in assets in the account. However, you do have to wait the typical 2 business days for settlement of funds.Nov 6, 2020



You can make money with your Robinhood investments by holding stocks that pay out dividends. But remember, there's an option to reinvest those profits back into additional shares. ... Reinvesting dividends allows you to earn compound interest. Click Here To Sign Up With Robinhood + Get 1 FREE Stock!Aug 12, 2020

Full Review

Robinhood is a free-trading app that lets investors trade stocks, options, exchange-traded funds and cryptocurrency without paying commissions or fees. ... That said, it's still a solid choice, and currently it's one of the few brokers that gives investors the opportunity to trade cryptocurrency.


Can you day trade without 25k?

PDT Rule. ... The PDT essentially states that traders with less than $25,000 in their margin account cannot make more than three day trades in a rolling five day period. So, if you make three day trades on Monday, you can't make any more day trades until next Monday rolls around again.

Why do day traders fail?
This brings us to the single biggest reason why most traders fail to make money when trading the stock the market: lack of knowledge. ... More importantly, they also implement strong money management rules, such as a stop-loss and position sizing to ensure they minimize their investment risk and maximize profits.Sep 3, 2020

35 Stocks Moving in Friday's Pre-Market Session

 

35 Stocks Moving in Friday's Pre-Market Session

Today 6:55 AM ET (Benzinga)Print

Gainers

  • China HGS Real Estate Inc. (NASDAQ: HGSH) rose 101.1% to $3.54 in pre-market trading after climbing over 21% on Thursday.
  • Cinedigm Corp. (NASDAQ: CIDM) rose 68.1% to $0.9414 in pre-market trading. Cinedigm recently announced eight of its linear streaming channels have launched on Rad streaming service.
  • ReTo Eco-Solutions, Inc. (NASDAQ: RETO) shares rose 38.8% to $0.9645 in pre-market trading after gaining over 3% on Thursday.
  • Sigma Labs, Inc. (NASDAQ: SGLB) rose 27.5% to $3.62 in pre-market trading after gaining over 4% on Thursday.
  • BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) rose 26.8% to $6.51 in pre-market trading after the company reported the FDA approval of ORLADEYO to prevent attacks in hereditary angioedema patients.
  • Star Peak Energy Transition Corp. (NYSE: STPK) shares rose 22.1% to $12.33 in pre-market trading.
  • Luminar Technologies (NASDAQ: LAZR) rose 19.7% to $27.50 in pre-market trading after climbing around 28% on Thursday.
  • Collective Growth Corporation (NASDAQ: CGRO) rose 19.3% to $11.80 in pre-market trading. Innoviz Technologies Ltd is reportedly deliberating a public listing in the U.S. through a merger with a special purpose acquisition company. Bloomberg reported that blank check company Collective Growth is seeking to raise between $100 million to $350 million in funding for the acquisition.
  • MIND Technology, Inc. (NASDAQ: MIND) rose 19.2% to $2.92 in pre-market trading after the company reported Q3 results.
  • Novan, Inc. (NASDAQ: NOVN) rose 19% to $0.6650 in pre-market trading after climbing over 8% on Thursday. Novan was recently granted U.S. patent titled 'Combinations and methods for the treatment and/or prevention of fungal infections.'

  • Sutro Biopharma, Inc. (NASDAQ: STRO) rose 17.7% to $20.00 in pre-market trading after the company reported interim data on STRO-002 Phase 1 dose-escalation study for patients with ovarian cancer.

  • Torchlight Energy Resources, Inc. (NASDAQ: TRCH) rose 17.6% to $0.5275 in pre-market trading after jumping 15% on Thursday.
  • PagerDuty, Inc. (NYSE: PD) rose 16.2% to $37.60 in pre-market trading after the company reported better-than-expected Q3 results. The company also issued strong Q4 and FY21 sales guidance .
  • CIIG Merger Corp. (NASDAQ: CIIC) rose 16% to $25.00 in pre-market trading after surging around 10% on Thursday.
  • Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) rose 14.7% to $1.56 in pre-market trading after surging 16% on Thursday. Foresight will showcase its mass screening COVID-19 symptom detection solution in the United Arab Emirates at GITEX Future Stars 2020 Dec. 7-9.
  • Cloudera, Inc. (NYSE: CLDR) rose 13.5% to $13.14 in pre-market trading after the company reported better-than-expected Q3 results and issued upbeat FY21 guidance.
  • Honda Motor Co., Ltd. (NYSE: HMC) shares rose 10.6% to $32.45 in pre-market trading.
  • Dynavax Technologies Corporation (NASDAQ: DVAX) shares rose 10.3% to $5.70 in pre-market trading.
  • United Microelectronics Corporation (NYSE: UMC) rose 10.3% to $8.55 in pre-market trading after climbing over 6% on Thursday.
  • Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 9.8% to $1.80 in pre-market trading after gaining over 7% on Thursday.
  • Zuora, Inc. (NYSE: ZUO) rose 5.8% to $12.46 in pre-market trading after reporting upbeat quarterly results.
  • DocuSign, Inc. (NASDAQ: DOCU) rose 4.4% to $241.18 in pre-market trading after the company reported better-than-expected Q3 results and issued strong sales guidance.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) fell 10.6% to $80.00 in pre-market trading despite reporting better-than-projected quarterly results.
  • Entera Bio Ltd. (NASDAQ: ENTX) shares fell 8.9% to $1.04 in pre-market trading. Entera Bio recently named Spiros Jamas as Chief Executive Officer.
  • Aehr Test Systems (NASDAQ: AEHR) fell 8.7% to $1.88 in pre-market trading.
  • Aehr Test Systems shares jumped 27% on Thursday after the company received a $4.3 million FOX-XP order.
  • Ever-Glory International Group, Inc. (NYSE: EVK) fell 8.6% to $4.80 in pre-market trading after jumping 150% on Thursday. The company released quarterly results last month.
  • Lizhi Inc. (NASDAQ: LIZI) fell 8.2% to $4.40 in pre-market trading. Lizhi shares jumped over 100% on Thursday after the company entered into in-car audio collaboration with Xpeng Motors.
  • NanoVibronix, Inc. (NASDAQ: NAOV) fell 8% to $1.04 in pre-market trading. NanoVibronix recently priced its 8.57 million share offering at $0.70at share.
  • Yext Inc (NYSE: YEXT) fell 5.4% to $18.27 in pre-market trading after the company issued weak Q4 sales guidance.
  • Cellectar Biosciences, Inc. (NASDAQ: CLRB) fell 5.2% to $2.21 in pre-market trading after surging over 19% on Thursday.
  • China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) shares fell 5.1% to $0.36 in pre-market trading. China SXT Pharmaceuticals shares jumped around 24% on Thursday after the company entered a 12 million share securities purchase agreement with an investor.
  • Marvell Technology Group Ltd. (NASDAQ: MRVL) fell 5.1% to $43.20 in pre-market trading.
  •  Marvell Technology reported in-line earnings for its third quarter, while sales missed estimates. The company also issued guidance for the current quarter.
  • Aqua Metals, Inc. (NASDAQ: AQMS) shares fell 5.1% to $1.12 in pre-market trading.
  • Clovis Oncology, Inc. (NASDAQ: CLVS) fell 5% to $5.15 in pre-market trading. Clovis Oncology’s S-3 showed registration for 10.14 million share common stock offering issuable upon conversion of $57.5 million convertible senior notes.
  • Ulta Beauty, Inc. (NASDAQ: ULTA) shares fell 3.6% to $279.00 in pre-market trading. Ulta Beauty reported upbeat earnings for its third quarter, while sales slightly missed views. Ulta Beauty’s comparable sales dropped 8.9% year over year, while the company expects Q4 comparable-store sales to drop 12% to 14%.

ANGI

 share  12.01   market   2.25  AVG 2.32 (2.95 ) % down  today 0.88%  purchase date  04 April 2024 2.34 3 April 2024 2.48 4 April 2024 2.30

Labels